Associated Press: Biosion Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial of BSI-082
February 6, 2026
Associated Press: Biosion Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial of BSI-082
yahoo! news: Biosion doses first patient in phase Ia/Ib BSI-082 trial for solid tumours
February 6, 2026
John Sarantopoulos, MD, associate professor, Department of Medicine, Division of Hematology and Oncology, and medical oncologist, Mays Cancer Center, was mentioned in this article. Read More
MSN.com: Biosion doses first patient in phase Ia/Ib BSI-082 trial for solid tumours
February 6, 2026
MSN.com: Biosion doses first patient in phase Ia/Ib BSI-082 trial for solid tumours
KSAT 12: South Texas amputee hopeful after launch of breakthrough program at UT Health San Antonio
February 6, 2026
KSAT 12: South Texas amputee hopeful after launch of breakthrough program at UT Health San Antonio
KENS 5: Healthy SA — Reducing both obesity and colon cancer risk with GLP-1s
February 4, 2026
KENS 5: Healthy SA — Reducing both obesity and colon cancer risk with GLP-1s

UT Health San Antonio researchers lead American Heart Association scientific statement on early recognition, intervention for post-stroke spasticity
February 4, 2026
UT Health San Antonio researchers lead American Heart Association scientific statement on early recognition, intervention for post-stroke spasticity

UT Health San Antonio researchers lead American Heart Association scientific statement on early recognition, intervention for post-stroke spasticity
February 4, 2026
An opportunity to reduce global burden of stroke-related disability Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu SAN ANTONIO, Feb. 4, 2026 – For many stroke survivors, recovery is derailed by painful muscle stiffness and involuntary spasms t …
Robotic surgery on forefront of HPV-related cancer treatment
February 3, 2026
Photo courtesy of Da Vinci This story was first published in the February 2026 issue of the Bexar County Medical Society’s San Antonio Medicine magazine. New face of head and neck cancer A healthy 40-year-old man visits his primary care physicia …
Mirage News: Cannabis, Drug Combo Shows Alzheimer’s Prevention Promise
February 2, 2026
Mirage News: Cannabis, Drug Combo Shows Alzheimer’s Prevention Promise
Investors Hangout: Exploring the Synergy: THC and Celecoxib for Alzheimer’s Prevention
February 2, 2026
Investors Hangout: Exploring the Synergy: THC and Celecoxib for Alzheimer’s Prevention
